Hypertension Trial, Recruiting NCT06859177 Sponsor: Maxima Medical Center Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT06859177
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are at least 18 years old
  • Pregnant people who are between 32 weeks and 0 days, and 36 weeks and 6 days along in their pregnancy
  • People who are carrying a single baby (not twins or more)
  • People who have a medical reason to have their baby monitored at least twice a week — for example, due to high blood pressure during pregnancy (pre-eclampsia), the baby not growing as expected (fetal growth restriction), or the waters breaking early (preterm pre-labor rupture of membranes)
  • People who do not meet any of the exclusion criteria for more than 24 hours after being admitted to hospital
  • People who have given both verbal and written agreement to take part

Who may not be able to join:

  • People who need medication given through a drip (intravenous medication)
  • People with a blood pressure reading above 160/110 mmHg
  • People whose baby has been found to have very poor or reversed blood flow in the umbilical cord on ultrasound
  • People diagnosed with a serious pregnancy complication involving the blood, liver, and platelets (known as HELLP syndrome)
  • People where a medical intervention or delivery is expected to be needed within the next 48 hours — for example, due to a concerning baby heart rate monitor result, active vaginal bleeding, signs the placenta may be separating early, meconium (baby's first stool) found in the waters, or signs of infection in the womb
  • People admitted with a diagnosis of severe infection causing low blood pressure (septic shock)
  • People who do not have enough understanding of Dutch or English to participate
  • People who are not able to understand how to use the monitoring device or the patient information provided
  • People where the baby or the mother has an irregular heart rhythm
  • People with a skin condition on their abdomen that would prevent the monitoring patch from being placed there
  • People who use an electrical stimulation device on or in their body, such as a TENS machine or a pacemaker, as this may interfere with the monitoring equipment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Judith O.E.H. van Laar, MD, PhD, Máxima Medical Center, Technical University of Eindhoven

Phone: +31408888384

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Maxima Medical Center
Registry
ClinicalTrials.gov
Start date
25 March 2025
Est. completion
1 June 2026

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Number of successful eCTG measurements on the first day of inclusion.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov